Although Graves' disease is a prevalent endocrine disorder, it is rare in prepubertal patients. Here, we describe the case of a middle childhood boy diagnosed with Graves' disease. The patient experienced exophthalmos, hyperactivity and overgrowth. Endocrinological tests revealed positivity for hyperthyroidism and thyrotropin receptor antibodies. Ultrasonography revealed an enlarged thyroid gland with increased blood flow. The onset of symptoms was estimated to have occurred around the age of 4 years based on the growth chart and past facial photographs. We speculate that it took more than 2 years from onset to diagnosis in this patient. The symptoms of Graves' disease in childhood, such as hyperactivity or overgrowth, may be overlooked as problems with developmental characteristics or growth effects. Although Graves' disease is rare in this age group, it should be considered in the differential diagnosis.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2025-264935DOI Listing

Publication Analysis

Top Keywords

graves' disease
20
hyperactivity overgrowth
12
disease
5
prepubertal graves'
4
disease hyperactivity
4
overgrowth early
4
early childhood
4
graves'
4
childhood graves'
4
disease prevalent
4

Similar Publications

Complement C5/C5a in the diagnosis and treatment of Graves ophthalmopathy: A Mendelian randomized study.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

October 2024

Department of Ophthalmology, Third Xiangya Hospital, Central South University, Changsha 410013, China.

Objectives: Graves' ophthalmopathy is a complex organ-specific autoimmune disease with an unclear pathogenesis. Complement component 5/5a (C5/C5a), a key element of the component system, may play a significant role in the disease's pathological process. This study aims to investigate the causal relationship between C5/C5a and Graves' ophthalmopathy using Mendelian randomization (MR) to provide new theoretical insights for its diagnosis and treatment.

View Article and Find Full Text PDF

Preventability of readmissions for patients with heart failure - A scoping review.

Heart Lung

March 2025

Health Services and Systems Research, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore; Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology, Brisbane, Queensland, Australia; National Heart Research Institute Singapore, National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609, Singapore.

Background: Heart failure (HF) remains a significant global health issue and poses challenges to patient families and healthcare systems through index hospitalizations and subsequent readmissions. The readmission rate has been utilized as a quality indicator, and a proportion of readmissions are perceived preventable. However, the definitions and measures of preventability remain unclear and inconsistent, lacking an explicit integration, analysis, and critique of current evidence.

View Article and Find Full Text PDF

The thyroid is essential for the metabolic processes in the body, and its imbalance can cause acute and chronic health issues. Autoimmune thyroid disease includes both Hashimoto's thyroiditis (HT) and Graves' disease (GD). HT is the most common cause of hypothyroidism, while GD is the most common cause of hyperthyroidism.

View Article and Find Full Text PDF

Introduction: Proven risk factors for thyroid orbitopathy (TO) are thyroid dysfunction, smoking, and high levels of thyrotropin receptor antibodies (TRAb), and the role of insulin-like growth factor 1 (IGF-1), the receptor for IGF-1 (IGF-1R), and antibodies to the receptor for IGF-1 (IGF-1RAb) are also debated. IGF-1R is overexpressed in fibroblasts and orbital lymphocytes in TO patients. It forms a functional complex and mediates signal transduction through thyroid stimulating hormone receptor (TSHR).

View Article and Find Full Text PDF

It is widely recognized that one autoimmune disorder is sometimes associated with an increased frequency of having another autoimmune condition. However, the simultaneous presentation of Ulcerative colitis and Graves' disease is an underreported occurrence in the medical literature. We present the case of a previously healthy 36-year-old female who presented with acute symptoms of ulcerative colitis and Graves' disease simultaneously, leading to the diagnosis of both conditions within a short time frame.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!